Sign in

Research summary ·

The relationship between endometrial cancer and urinary incontinence: systematic review.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This systematic review looked at endometrial cancer and urinary incontinence. Incontinence is a common and upsetting problem, the abstract says. The review asked how common it is and what may cause it. It also asked what it means for care. The team searched PubMed, Scopus and other databases. It used recent English-language studies. The studies differed a lot, so the results were summarised in words.

What they found

The review included studies with 955 patients and 85 healthcare professionals. Incontinence was highly prevalent but often undermanaged after this cancer and its treatments. Removing lymph nodes may add to urinary symptoms. This did not reach statistical significance. Radiotherapy had mixed effects. It may ease stress incontinence but add to pelvic floor problems. Obesity and age were important risk factors on their own.

What it means for patients

The authors say incontinence is a common, important problem after this cancer. They say addressing it must become a priority in survivorship care. They say future work should build validated screening tools. They also name evidence-based guidelines and integrated care models.

Why it is not certain yet

The studies were too different to pool. The abstract does not say how good they were. The lymph node link was not statistically significant. Radiotherapy effects were mixed. A review can only be as good as the studies in it.

Source

The relationship between endometrial cancer and urinary incontinence: systematic review.

PubMed · PMID 42890221

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Endometrial cancer publications
The relationship between endometrial cancer and urinary incontinence: systematic review. · Endometrial cancer news explained – Frontlight Research